GRI Bio Inc. • GRI

Capital at risk.

About GRI Bio Inc.
Ticker
info
GRI
Trading on
info
NASDAQ
ISIN
info
US3622AW4030
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. W. Marc Hertz Ph.D.
Headquarters
info
2223 Avenida de la Playa, LA Jolla, CA, United States, 92037
Employees
info
3
Website
info
gribio.com
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.
Metrics
BasicAdvanced
Market cap
info
$3.1M
P/E ratio
info
0.03
EPS
info
$40.06
Dividend Yield
info
0.00%
Beta
info
-2.11
Forward P/E ratio
info
0
EBIDTA
info
$-9.4M
Ex dividend date
info
-
Price & volume
Market cap
info
$3.1M
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0.03
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0.03
Price to sales
info
0
Price to book
info
2.55
Earnings
EPS
info
$40.06
EPS estimate (current quarter)
info
-$3.79
EPS estimate (next quarter)
info
-$1.01
EBITDA
info
$-9.4M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-2.11
52-week High
info
$38.93
52-week Low
info
$1.10
50-day moving average
info
$1.50
200-day moving average
info
$7.85
Short ratio
info
0.31
Short %
info
5.57%
Management effectiveness
ROE (TTM)
info
-467.95%
ROA (TTM)
info
-136.04%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
2.3M
Float
info
2.1M
Insiders %
info
0.02%
Institutions %
info
0.21%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$22.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$4.92
-
-
Q2 • 24Beat
-$0.67
-$0.73
8.22%
Q3 • 24Beat
-$7.34
-$5.44
-35.00%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$2.3M
$-1.9M
-84.73%
Q4 • 24
$0M
$-3M
-∞%
Q1 • 25
-100.00%
56.45%
∞%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$5.7M
$1.7M
29.74%
Q4 • 24
$4M
$2.8M
70.19%
Q1 • 25
-29.57%
66.20%
135.97%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-2M
$0M
$2.3M
$-2M
Q4 • 24
$-1.7M
-
$-0M
$-1.7M
Q1 • 25
-13.16%
-
-100.48%
-13.16%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a GRI Bio Inc. share?
Collapse

GRI Bio Inc. shares are currently traded for undefined per share.

How many shares does GRI Bio Inc. have?
Collapse

GRI Bio Inc. currently has 2.3M shares.

Does GRI Bio Inc. pay dividends?
Collapse

No, GRI Bio Inc. doesn't pay dividends.

What is GRI Bio Inc. 52 week high?
Collapse

GRI Bio Inc. 52 week high is $38.93.

What is GRI Bio Inc. 52 week low?
Collapse

GRI Bio Inc. 52 week low is $1.10.

What is the 200-day moving average of GRI Bio Inc.?
Collapse

GRI Bio Inc. 200-day moving average is $7.85.

Who is GRI Bio Inc. CEO?
Collapse

The CEO of GRI Bio Inc. is Dr. W. Marc Hertz Ph.D..

How many employees GRI Bio Inc. has?
Collapse

GRI Bio Inc. has 3 employees.

What is the market cap of GRI Bio Inc.?
Collapse

The market cap of GRI Bio Inc. is $3.1M.

What is the P/E of GRI Bio Inc.?
Collapse

The current P/E of GRI Bio Inc. is 0.03.

What is the EPS of GRI Bio Inc.?
Collapse

The EPS of GRI Bio Inc. is $40.06.

What is the PEG Ratio of GRI Bio Inc.?
Collapse

The PEG Ratio of GRI Bio Inc. is null.

What do analysts say about GRI Bio Inc.?
Collapse

According to the analysts GRI Bio Inc. is considered a buy.